Study shows Toviaz is effective in reducing urge urinary incontinence in patients with overactive bladder after suboptimal response to Detrol LA
3 August 2012 | By Pfizer
Phase 4 study has met its primary endpoint...
List view / Grid view
3 August 2012 | By Pfizer
Phase 4 study has met its primary endpoint...
31 July 2012 | By Pfizer
Pfizer also provides update on Tofacitinib filing in the U.S.
23 July 2012 | By Pfizer
Co-primary clinical endpoints not met in study of patients with Alzheimer’s disease who carry the ApoE4 genotype...
20 July 2012 | By Pfizer
“The CHMP’s positive opinion brings us a step closer..."
19 July 2012 | By Pfizer
“The Court’s decision recognizes the infringement & validity of our LYRICA® patents..."
19 July 2012 | By Pfizer
The EMA has accepted for review the MAA for bazedoxifene/conjugated estrogens...
10 July 2012 | By David Sek, Research Scientist, Pfizer
One of the key factors in stabilising proteins is determining the optimal pH and buffer system to provide adequate solubility and stability. Currently, three buffers, citrate, phosphate and acetate, make up the majority of buffers used in parenteral pharmaceuticals approved by the FDA, but less precedented excipients are certainly available…
In this Stem Cells In-Depth Focus: Stem cell therapies: Assuring safety; Role of pluripotent stem cells in neurotoxicology testing: Impacts and applied innovations...
26 June 2012 | By Bristol-Myers Squibb Company / Pfizer
Additional information requested from ARISTOTLE trial results...
20 June 2012 | By Pfizer
Pfizer issued the following statement...
19 June 2012 | By Pfizer
Detailed study results to be presented...
18 June 2012 | By Pfizer
Tafamidis is a novel, investigational medication for the treatment of TTR-FAP...
15 June 2012 | By Pfizer
Pfizer has announced the launch of a new Web site, “Campaign Against Migraine”, to help migraine sufferers across the country...
25 May 2012 | By Pfizer
The CHMP of the EMA has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU)...
23 May 2012 | By Pfizer
Olivier will succeed David Simmons...